| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |